HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

National uniformity compromises can be reached, Sen. Kennedy says.

This article was originally published in The Rose Sheet

Executive Summary

NATIONAL UNIFORMITY: "FAIR OVERALL COMPROMISE IS STILL POSSIBLE," SEN. KENNEDY told Senate Majority Leader Trent Lott (R-Miss.) in floor remarks made July 31 prior to the August congressional recess. Sen. Edward Kennedy (D-Mass.), the Labor & Human Resources Committee ranking minority member, suggested that "acceptable compromises can be reached" on the national uniformity provision that preempts states' authority to regulate cosmetics and OTCs. The clause is included in Sen. James Jeffords' (R-Vt.) FDA reform bill (S 830).

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel